Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PrimePro/PrimeMSK Stem Cell Therapy for Chronic and Acute Conditions
NCT04684602Phase 2Recruiting
- Sponsor
- Thomas Advanced Medical LLC
- Start
- Jul 2020
- Primary completion
- Jul 2030
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of PrimePro in autoimmune diseases, cardiac morbidity, diabetes mellitus (DM), Dermatopathy, musculoskeletal disorders (MSDs), sponsored by Thomas Advanced Medical LLC. Started Jul 2020; status: recruiting.
02
Drugs
PrimePro
03
Conditions
autoimmune diseasescardiac morbiditydiabetes mellitus (DM)Dermatopathymusculoskeletal disorders (MSDs)
Beyond the preview
Go deeper on NCT04684602.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04684602.